Short description
Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions.
Description
Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licencing of innovative drug candidates, and consulting arrangements.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Hamburg, Hamburg, Germany, Europe
Founded on
January 1, 1993
Exited on
November 4, 2021
Went public on
November 4, 2021
Stock symbol
EVO
Non-profit?
No
Acquired?
No
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccessforu, Noaccess, Noaccessforu, Uh Ohhhh, Noaccess, Cannot Access, Noaccess, Cannot Access, Noaccess, Blurry Noaccess, Cannot Access
Sign in for full access
Founders
Charles Weissmann, Freimut Leidenberger, Heinrich M. Schulte, Karsten Henco, Manfred Eigen, Rudolf Rigler, Ulrich Aldag
Funding rounds count
26
Portfolio organisations count
Absolutely Noaccess, Nopepepe
Sign in for full access
Lead investments count
5
Exits count
Cannot Access, Noaccess
Sign in for full access
IPO exits count
3